NOT KNOWN FACTUAL STATEMENTS ABOUT AZ-23

quinupristin/dalfopristin will improve the degree or outcome of efavirenz by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.quinupristin/dalfopristin will improve the amount or outcome of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Lower acalabru